People · Operator
Named in public records as an officer, director or promoter · active 2010–2023 · Biotechnology, Pharmaceuticals, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ValCor Cath Inc. | — | Biotechnology | Series A | $4.3M | $38.3M | 2023 |
| FST Life Sciences, Inc. | — | Pharmaceuticals | Seed | $1.8M | $41.2M | 2010 |
| Ureteral Stent Co | — | Other Health Care | Seed | $1.2M | $30.7M | 2020 |
Michael Bunker at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Bunker on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Andrew McColm | 1 | 3 |
| Thomas Holleran | 1 | 1 |
| Howard Kasi Bobrow | 1 | 1 |
| P. Kasi Ramanathan | 1 | 1 |
| Gary Kasi Smith | 1 | 1 |
| Matthew Kasi Pollman | 1 | 1 |
| Eugene Jung | 1 | 1 |
| Diane Chelsea | 1 | 1 |
| Lee Ponsky | 1 | 1 |
| Rafid Fadul | 1 | 1 |
| Michael Attias | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.